The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
VJVirtual | Novel therapies for MPNs
Naveen Pemmaraju, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, talks on emerging novel therapies for the treatment of myeloproliferative neoplasms (MPNs), including new classes of agents such as bromodomain inhibitors, Bcl-xL inhibiton, HSP inhibitors, aurora kinase inhibitors and many more. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
